Search plants, projects, owners, and states
9.2 MW Natural Gas Fired Combustion Turbine (4 MW) + Petroleum Liquids (5 MW) standby in Pitt, NC
9.2 MW
Nameplate Capacity
8
Generators
units
Hybrid (2)
Technology
Natural Gas Fired Combustion Turbine + Petroleum Liquids
1987
Operating Since
Coordinates
35.6660, -77.3574
County
Pitt, NC
Nearby Plants
Forward-looking, asset-specific exposure analytics combining climate hazards, generation variability, and counterparty risk into a single decision-grade view. Powered by InfraRisk.
See the full risk decomposition + scenarios for this asset.
| Field | EIA | GEM | Wikidata |
|---|---|---|---|
| Operator | Patheon Manufacturing Service LLC | — | — |
| Owner(s) | Patheon Manufacturing Service LLC | — | — |
| Status | Standby | — | — |
DSM Pharmaceuticals is a 9.2 MW hybrid power plant located in Pitt County, North Carolina. The plant began operating in 1987 and is operated by Patheon Manufacturing Service LLC. The primary fuel source is distillate fuel oil (DFO), and the plant utilizes both natural gas-fired combustion turbine and petroleum liquids technologies across its eight generators. It operates within the Duke Energy Progress East balancing authority and the SERC NERC region.
In terms of its size, DSM Pharmaceuticals ranks as the 8th largest power plant out of 45 in North Carolina, and 358th out of 886 nationally. The plant's latest annual generation was 46 MWh, resulting in a capacity factor of 0.1%.
Generated from EIA, GEM, and public data sources
Grid Region
Southeast
Market
SEEM Participant
NERC Region
SERC — SERC Reliability Corporation
Balancing Authority
Duke Energy Progress East (CPLE)
Grid Voltage
13.2 kV
Regulatory Status
NR — Non-Regulated
Entity Type
Industrial
Sector
Industrial CHP
Monthly net generation as reported to EIA-923 — useful for historical context. Confidence varies sharply by fuel type; the band above and the “About this data” button explain the caveats specific to this plant and how InfraSure’s in-house model handles them.
2 MWh
Latest Month
46 MWh
Annual Generation
0.1%
Capacity Factor
Forward-looking generation outlook with probabilistic ranges across weather, demand, and policy scenarios. Powered by InfraSure's generation modeling stack.
See the full forecast + scenario decomposition for this asset.
CO₂ Intensity
908 lb/MWh
Low-utilization plant — per-MWh rate is dominated by startup/standby emissions; not directly comparable to baseload averages.
NOx
18 lb/MWh
SO₂
2 lb/MWh
CH₄
0.037 lb/MWh
N₂O
0.007 lb/MWh
Capacity Factor
0.0%
Annual Net Gen
0 GWh
CO₂eq
911 lb/MWh
Subregion
SERC Virginia/Carolina
2013
$965/kW
Est. Construction Cost
Total estimated cost: $8.9M
Forward revenue, DSCR bands, and refinancing risk projected under price, demand, and policy scenarios. Powered by InfraSure's asset cashflow stack.
See the full revenue + DSCR projection for this asset.
This plant's balancing authority participates in the Southeast Energy Exchange Market (SEEM). SEEM is a bilateral exchange — no public nodal pricing.
No wholesale contracts disclosed in FERC EQR for this plant.
FERC EQR captures bilateral wholesale energy + capacity contracts ≥$1M/yr filed quarterly by jurisdictional sellers — covers renewable PPAs, thermal energy sales agreements, capacity contracts, and tolling agreements alike. Many plants don't appear: regulated-utility output flows to ratepayers via cost-of-service rather than bilateral contracts; small projects fall below the filing threshold; tax-equity-financed renewables route offtake to investors not utilities; merchant plants sell into ISO clearing markets without bilateral contracts. News-extracted buyer facts (below) may surface contracts disclosed only through announcements.
No insights linked yet for this plant.
Insights enrichment runs on demand — we have the pipeline, we just haven't fetched coverage for this plant yet. Request a detailed re-run and we'll add it.
No Ask reports yet for this entity.
Ask about DSM PharmaceuticalsForward forecasts, scenario decomposition, and risk-decision tooling for this asset.